i FEEL YA, management shouldn't have used max possible:20:1, $4.20 was too high to sustain psychologically after the beat-downs on this stock and failure of Neuvax, shoulda stuck with max. 10:1 and I emailed their IR with my thoughts but lotsa good that did, their PR's aren't helping much --
I also suggested they hurry and buy back some rev=-producers they sold, fat chance fast, but plus side, new management wants to do that he said:
we got our own shorters here and all over, led by Crummer and Old Fish Eyes Feuerstein and even they're not bothering with this now --
it will find its equilibrium but needs a REAL catalyst not these reports of upcoming reports on progress, there's too much skepticism now.
They need results from GALE series and Roche dual trials then it can shoot up fast with this new SS.
I can't sell b/c compared to early June my shres are almost worthless, let's hope the shorts move on to something other than something that is trying to save lives, however disappointingly so far, how 'bout shorting a toxic chemical company, Shorts huh? Give biotechs a break, yeah they're easy b/c high investment required but shorts: go away.
